Get Breaking Alerts on Stocks Before The Mainstream Media

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address
We guarantee you to keep your privacy
Connect with us
Financial Press
the-tell:-these-are-the-stocks-to-short-when-a-covid-vaccine-is-ready,-says-jpmorgan
the-tell:-these-are-the-stocks-to-short-when-a-covid-vaccine-is-ready,-says-jpmorgan

Breaking

The Tell: These are the stocks to short when a COVID vaccine is ready, says JPMorgan

The Tell


In this image courtesy of the Henry Ford Health System, volunteers are given the Moderna mRNA-1273 Coronavirus Efficacy vaccine on August 5, 2020, in Detroit, Michigan.


Henry Ford Health System/Agence France-Presse/Getty Images

Executives at drugmakers Pfizer
PFE,
+1.01%

and Moderna
MRNA,
-0.70%

say their COVID-19 vaccine candidates could be ready, at least for limited use, by the end of the year. It will be good — make that, great — news for the economy if the vaccines are effective enough that face-to-face interactions can once again resume without much fear of spreading, or contracting, the new coronavirus. But in the stock market, it won’t universally be good news, as some companies have thrived during the current pandemic.

Get Breaking Stock Alerts

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address
We are Spam free & Secure 🙂

Strategists at JPMorgan have put together a list of companies that are at risk of steep drops. They are at the “upper echelon of momentum and have crowded positioning, that could see the second derivative of their profit growth decrease as consumer / corporate activity normalizes,” said the JPMorgan team. Some of the names, like Zoom Video Communications
ZM,
-1.94%
,
are obvious, but the list also includes companies including education technology provider Chegg
CHGG,
-0.46%

and Central Garden and Pet Co.
CENTA,
+0.48%

that aren’t as well known.

This group of stocks has outperformed the S&P 500 by about 9% this year.

The strategists also discussed the U.S. election, and pointed out their basket of stocks tied to a victory by former Vice President Joe Biden is outperforming the basket tied to a victory by President Donald Trump by 66% this year.

“Given the large divergence between these two baskets (i.e. similar to momentum/value), coupled with our expectation that COVID-19 headline risk likely declines postelection, we see an increasingly compelling case for value in the coming period. Deep value, namely energy and financials, would likely be key beneficiaries of an ‘orderly’ Trump victory and could see a large short squeeze. Under a Biden scenario we could also see profit-taking from high momentum stocks, especially as investors start to price in risk of higher capital-gains tax,” they said.

Written By

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Breaking

Some of the most talked-about investing bets of the past year aren’t the companies that benefited from the COVID-19 lockdowns or business activity going...

Breaking

Bond Report Published: Nov. 30, 2020 at 8:32 a.m. ET U.S. Treasury yields were trading higher on early Monday’s trade as investors eyed progress...

Breaking

The U.K. is set to become the first country in the world to approve a COVID-19 vaccine, with the country’s medical regulator likely to...

Breaking

Smidcap stocks are on fire. The Russell 2000 RUT, +0.55% is up over 19% this month compared to 10% for the S&P 500 index...

Get Breaking Stock Alerts

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address
We are Spam free & Secure :)

Get Breaking Stock Alerts

Email address

Get Breaking Stock Alerts

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address